Literature DB >> 25754666

Candida-streptococcal mucosal biofilms display distinct structural and virulence characteristics depending on growth conditions and hyphal morphotypes.

M M Bertolini1, H Xu1, T Sobue1, C J Nobile2, A A Del Bel Cury3, A Dongari-Bagtzoglou1.   

Abstract

Candida albicans and streptococci of the mitis group form communities in multiple oral sites, where moisture and nutrient availability can change spatially or temporally. This study evaluated structural and virulence characteristics of Candida-streptococcal biofilms formed on moist or semidry mucosal surfaces, and tested the effects of nutrient availability and hyphal morphotype on dual-species biofilms. Three-dimensional models of the oral mucosa formed by immortalized keratinocytes on a fibroblast-embedded collagenous matrix were used. Infections were carried out using Streptococcus oralis strain 34, in combination with a C. albicans wild-type strain, or pseudohyphal-forming mutant strains. Increased moisture promoted a homogeneous surface biofilm by C. albicans. Dual biofilms had a stratified structure, with streptococci growing in close contact with the mucosa and fungi growing on the bacterial surface. Under semidry conditions, Candida formed localized foci of dense growth, which promoted focal growth of streptococci in mixed biofilms. Candida biofilm biovolume was greater under moist conditions, albeit with minimal tissue invasion, compared with semidry conditions. Supplementing the infection medium with nutrients under semidry conditions intensified growth, biofilm biovolume and tissue invasion/damage, without changing biofilm structure. Under these conditions, the pseudohyphal mutants and S. oralis formed defective superficial biofilms, with most bacteria in contact with the epithelial surface, below a pseudohyphal mass, resembling biofilms growing in a moist environment. The presence of S. oralis promoted fungal invasion and tissue damage under all conditions. We conclude that moisture, nutrient availability, hyphal morphotype and the presence of commensal bacteria influence the architecture and virulence characteristics of mucosal fungal biofilms.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Candida; Streptococcus; biofilms; infection models

Mesh:

Substances:

Year:  2015        PMID: 25754666      PMCID: PMC4491045          DOI: 10.1111/omi.12095

Source DB:  PubMed          Journal:  Mol Oral Microbiol        ISSN: 2041-1006            Impact factor:   3.563


  44 in total

1.  Development of a novel three-dimensional in vitro model of oral Candida infection.

Authors:  A Dongari-Bagtzoglou; H Kashleva
Journal:  Microb Pathog       Date:  2006-04-19       Impact factor: 3.738

Review 2.  Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders.

Authors:  Antonio Cassone; Roberto Cauda
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

3.  A recently evolved transcriptional network controls biofilm development in Candida albicans.

Authors:  Clarissa J Nobile; Emily P Fox; Jeniel E Nett; Trevor R Sorrells; Quinn M Mitrovich; Aaron D Hernday; Brian B Tuch; David R Andes; Alexander D Johnson
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

4.  The RIM101 signal transduction pathway regulates Candida albicans virulence during experimental keratomycosis.

Authors:  Xiaoyong Yuan; Bradley M Mitchell; Xia Hua; Dana A Davis; Kirk R Wilhelmus
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

5.  Predisposing conditions for Candida spp. carriage in the oral cavity of denture wearers and individuals with natural teeth.

Authors:  Juliana Pereira Lyon; Sérgio Carvalho da Costa; Valéria Maria Gomes Totti; Maira Forestti Vieira Munhoz; Maria Aparecida de Resende
Journal:  Can J Microbiol       Date:  2006-05       Impact factor: 2.419

6.  Virulence and pathogenicity of Candida albicans is enhanced in biofilms containing oral bacteria.

Authors:  Yuri Wanderley Cavalcanti; Daniel James Morse; Wander José da Silva; Altair Antoninha Del-Bel-Cury; Xiaoqing Wei; Melanie Wilson; Paul Milward; Michael Lewis; David Bradshaw; David Wynne Williams
Journal:  Biofouling       Date:  2015       Impact factor: 3.209

7.  Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1.

Authors:  J F Staab; S D Bradway; P L Fidel; P Sundstrom
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

8.  Antagonistic interplay of Swi1 and Tup1 on filamentous growth of Candida albicans.

Authors:  Xuming Mao; Yandong Li; Huafeng Wang; Fang Cao; Jiangye Chen
Journal:  FEMS Microbiol Lett       Date:  2008-06-28       Impact factor: 2.742

Review 9.  Interactions of Candida albicans with host epithelial surfaces.

Authors:  David W Williams; Rachael P C Jordan; Xiao-Qing Wei; Carlos T Alves; Matt P Wise; Melanie J Wilson; Michael A O Lewis
Journal:  J Oral Microbiol       Date:  2013-10-21       Impact factor: 5.474

Review 10.  Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease.

Authors:  H Xu; H F Jenkinson; A Dongari-Bagtzoglou
Journal:  Mol Oral Microbiol       Date:  2014-06       Impact factor: 3.563

View more
  19 in total

1.  Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model.

Authors:  T Sobue; M Bertolini; A Thompson; D E Peterson; P I Diaz; A Dongari-Bagtzoglou
Journal:  Mol Oral Microbiol       Date:  2018-02-20       Impact factor: 3.563

2.  Candida albicans and Pseudomonas aeruginosa Interact To Enhance Virulence of Mucosal Infection in Transparent Zebrafish.

Authors:  Audrey C Bergeron; Brittany G Seman; John H Hammond; Linda S Archambault; Deborah A Hogan; Robert T Wheeler
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

3.  Streptococcus oralis and Candida albicans Synergistically Activate μ-Calpain to Degrade E-cadherin From Oral Epithelial Junctions.

Authors:  Hongbin Xu; Takanori Sobue; Martinna Bertolini; Angela Thompson; Anna Dongari-Bagtzoglou
Journal:  J Infect Dis       Date:  2016-05-13       Impact factor: 5.226

4.  Transcriptome analysis of Streptococcus gordonii Challis DL1 indicates a role for the biofilm-associated fruRBA operon in response to Candida albicans.

Authors:  A M Jesionowski; J M Mansfield; J L Brittan; H F Jenkinson; M M Vickerman
Journal:  Mol Oral Microbiol       Date:  2015-09-25       Impact factor: 3.563

5.  Role of Candida albicans secreted aspartyl protease Sap9 in interkingdom biofilm formation.

Authors:  Lindsay C Dutton; Howard F Jenkinson; Richard J Lamont; Angela H Nobbs
Journal:  Pathog Dis       Date:  2016-01-14       Impact factor: 3.166

Review 6.  The oral microbiota: dynamic communities and host interactions.

Authors:  Richard J Lamont; Hyun Koo; George Hajishengallis
Journal:  Nat Rev Microbiol       Date:  2018-12       Impact factor: 60.633

Review 7.  Oropharyngeal Candidiasis: Fungal Invasion and Epithelial Cell Responses.

Authors:  Marc Swidergall; Scott G Filler
Journal:  PLoS Pathog       Date:  2017-01-12       Impact factor: 6.823

8.  Effect of a Lactobacillus Salivarius Probiotic on a Double-Species Streptococcus Mutans and Candida Albicans Caries Biofilm.

Authors:  Wirginia Krzyściak; Dorota Kościelniak; Monika Papież; Palina Vyhouskaya; Katarzyna Zagórska-Świeży; Iwona Kołodziej; Beata Bystrowska; Anna Jurczak
Journal:  Nutrients       Date:  2017-11-14       Impact factor: 5.717

9.  A Sustained-Release Membrane of Thiazolidinedione-8: Effect on Formation of a Candida/Bacteria Mixed Biofilm on Hydroxyapatite in a Continuous Flow Model.

Authors:  Mark Feldman; Julia Shenderovich; Eran Lavy; Michael Friedman; Doron Steinberg
Journal:  Biomed Res Int       Date:  2017-10-10       Impact factor: 3.411

10.  Candida albicans mannans mediate Streptococcus mutans exoenzyme GtfB binding to modulate cross-kingdom biofilm development in vivo.

Authors:  Geelsu Hwang; Yuan Liu; Dongyeop Kim; Yong Li; Damian J Krysan; Hyun Koo
Journal:  PLoS Pathog       Date:  2017-06-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.